n ecrotizing enterocolitis (NEC) is the leading cause of death from gastrointestinal disease in the preterm infant (1) . Up to 40 percent of afflicted premature infants require intestinal resection with a mortality rate of almost 50 percent and a significant subsequent morbidity (e.g., short bowel syndrome, etc) (2) . The approach to management of the infant with NEC has not changed in the past 30 y and the outcome is generally as poor today as it was three decades ago (3) . These dismal results in current therapy for NEC highlight the urgent need for a better understanding of its pathogenesis and the importance of establishing novel, new therapies.
It has been suggested that an abnormal response by the premature infant to colonizing intestinal microbiota may contribute to the susceptibility of developing NEC. The incidence and mortality of NEC is highest in premature infants (1, 4, 5) implicating gut immaturity as an additional risk factor. Intestinal maturation is affected by multiple factors such as intrinsic timing, exposure to trophic factors and cytokines in amniotic fluid, and the initial interaction with colonizing microbes (6, 7) . For example, amniotic fluid and breast milk contain hydrocortisone (HC) that interacts with the gut during the perinatal period to stimulate a rapid transition to an adult enterocyte phenotype as reported with the induction of sucrose and galactosyltransferase and enterocyte plasma membrane maturation in previous studies, (6, 8, 9) which may attenuate the expression of the disease.
NEC is characterized by a severe inflammation and necrosis of the intestine. Recent evidence has suggested that the nature of the Toll-like receptor 4 (TLR4) expressions within epithelium may contribute to the inflammatory response to enteric bacteria resulting in the development of NEC (3, 10) . The function of TLR 4 signaling is determined, in part, by the cell in which it is expressed, by its selective use of signal transduction and by its cellular location and trafficking capacity (11) (12) (13) (14) (15) . Although NEC can cause damage throughout the gut, it primarily evokes inflammation and necrosis in the distal small intestine and colon (4, 5) . Unfortunately, the cellular distribution and trafficking of TLR4 in colonic cells is not well understood. Accordingly, in this study, we determined the location and degree of expression of TLR4 in immature human and mouse colonocytes and investigated whether a trophic hormone (HC) could affect its distribution and response.
RESULTS

TLR4 Expression in Human Fetal Colonic Epithelium
To investigate TLR4 expression in developing human colonic epithelium, we localized and quantitated the receptor at gestational ages 10 (Figure 1a) , 16 ( Figure 1b ) and 21 wk (Figure 1c ) and at 4 mo postpartum (considered mature tissue) (Figure 1d ) by immunofluorescence confocal microscopy. TLR4 was expressed on the apical surface, within the cytoplasm, at the basal cellular level of fetal colonic epithelium and in the lamina propria from 10 to 21 wk. At 4 mo postpartum, human colonic TLR4 was scattered in crypt epithelial cells, lamina propria (Figure 1d ) and occasionally detected on the apical surface and within the cytoplasm (data not shown). The quantity of TLR4 in fetal colonic epithelium increased to its highest level at gestational age 16-wk and then steadily decreased, reaching its lowest level at 4 mo postpartum (Figure 1f) . The surface to cytoplasm ratio of TLR4 was highest at gestational age 10 and 16 wk, but decreased 27% by gestational age 21 wk and an additional 26% by 4 mo postpartum (Figure 1g) . These results suggest an increased expression of TLR4 in human fetal colonic epithelium that may be developmentally regulated, perhaps due to an intrinsic timing mechanism. A larger percentage of Confocal microscopy image (a-e) left pane: overlayer of human colon tissues stained with a phycoerythrin (PE) labeled anti-human TLR4 antibody (red) and a fluorescein isothiocyanate (FITC) labeled anti-phospholipid antibody (green) (as a cell membrane marker); right pane: overlayer of phospholipid-FITC and DRAQ5(blue) (as a cell nuclear marker). Magnification: ×1,000; scale bar: −20 µm. (a) An area classification of colonic epithelium in a 10-wk human colon. The thickness of the surface (line 1) and basal membrane (line 2) both are 3.75 µm. Surface area is surrounded by a yellow line; cytoplasm area is surrounded by a blue line; and basal area was surrounded by a dark yellow line. (b) TLR4 expression at gestational age 16 wk, (c) 21 wk, and (d) 4 mo after birth. (e) Negative control for anti-human TLR4 antibody in a human fetal 16-wk colonic section. (f) The average mean fluorescence intensity of TLR4 expression within the whole epithelial area (n = 3-4) for each group, error bars represent SD, compared to a 10-wk gestational age group (*P < 0.05, **P < 0.01). (g) Histogram of surface to cytoplasm ratio of TLR4 fluorescence intensity in colonic sections (n = 3-4) for each group, error bars represent SD, compared to a 10-wk gestational age group (*P < 0.05, † P < 0.001). TLR4 was present on the surface of enterocytes at earlier gestational ages.
TLR4 Expression in Mouse Colonic Epithelium
To study the ontogeny of TLR4 expression in mouse colon, we localized and quantitated TLR4 in C57BL/6J mice at embryonic day E 16.5 (Figure 2a ), E 18.5 (Figure 2b) , and postnatal days 1 (Figure 2c), 3(Figure 2d ), 21( Figure 2e ) and at 10 wk (Figure 2f ) by immunofluorescent confocal microscopy. The quantity of TLR4 was high at E 16.5 and continued to increase until postnatal day 1 when it reached its peak and then decreased from postnatal day 3 to reach its lowest level at 
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Articles 10 wk (Figure 2h) . However, the surface to cytoplasm ratio of TLR4 was highest at E 16.5, and decreased at E18.5 through postnatal day 1 and continued to decrease until it reached the lowest level by 10 wk after birth (Figure 2i) . These results suggest that the quantity and distribution of TLR4 also appears to be developmentally regulated in mouse colonic epithelium as evidenced by the observation showing a higher surface to cytoplasm distribution of TLR4 at the earlier gestational age. However, after birth presumably as the colon was exposed to colonizing microbiota, surface distribution of TLR4 rapidly decreased at the first day of the life and continued to decrease until 10 wk.
HC Exposure Alters the TLR4 Response to LPS in Fetal Enterocytes
To investigate if the trophic factor HC can alter the TLR4 signaling response to lipopolysaccharide (LPS) in immature colon, human fetal colon (FHC) cells were stimulated with or without HC at doses found in amniotic fluid for 5 d and then exposed to LPS (15 µg/ml). After 45 min, supernatant interleukin (IL)-6 levels significantly increased in the control group and remained high at 6 h ( Figure 3a) . In contrast, LPS-stimulation failed to induce an IL-6 response in HC-treated (Figure 3b ). We further determined the impact of maturation on LPS-TLR4 signaling by exposure of an adult human primary colonic epithelial cell line (NCM 460) to LPS. After 45 min, supernatant IL-6 levels significantly decreased and only partially recovered at 6 h (Figure 3c ). These results suggest that the trophic hormone HC can alter the LPS-induced TLR4 response from an immature to one comparable to a mature pattern.
HC exposure to LPS in fetal mouse colon
To investigate if HC can affect TLR4 signaling in immature mouse colon, pregnant C57BL/6J mice were subcutaneously injected with HC once at a dose of 50 mg/kg on E 14.5 or with the same volume of phosphate-buffered saline (PBS). A fetal colonic organ culture was established at E 18.5 and the colonic tissues exposed to LPS. In the PBS-treated control group, supernatant IL-6 levels increased significantly at 45 min and continued to increase at 6 h (Figure 4a) . However, in the HC pretreated group, IL-6 levels decreased significantly at 45 min and only recovered to baseline at 6 h (Figure 4b) . To compare the LPS-induced TLR4 reaction in mature mouse colonic tissue, 10-wk postpartum C57BL/6J colonic tissues were challenged with LPS in organ culture. After 45 min, the supernatant IL-6 levels decreased significantly and returned Articles Meng et al.
to baseline levels at 6 h (Figure 4c) . These results suggest that the TLR4response to LPS was different between immature and mature colon. Immature colon, expressing a greater quantity and more surface TLR4, had a greater IL-6 response to LPS stimulation than did mature colon, which expressed less total and more intracellular TLR4. Furthermore, pretreatment with HC resulted in the immature colon exhibiting a more mature response to LPS. These observations suggest that with intestinal maturation LPS-induced TLR4 signaling is reduced to a more mature response.
HC Effect on the Surface to Cytoplasm TLR4 Ratio in Human Fetal Colonic Tissue
To investigate if HC reduced LPS-induced TLR4 signaling by affecting the surface TLR4 expression, human fetal colonic tissues at 16 wk gestation (n = 3) were exposed to PBS (Figure 5a ) or HC (Figure 5b ) in organ culture. After 20 h, the surface to cytoplasm distribution of TLR4 was noted to be significantly decreased in HC-treated organ culture (Figure 5c ). This observation suggests that the HC effect appears to reduce the surface to cytoplasm ratio of TLR4 and may account for the reduction of the LPS-induced TLR4 signaling in immature colonic epithelial cells exposed to trophic factors in utero.
HC Effects on the Surface to Cytoplasm Ratio of TLR4 in Human Fetal Colonic Cells
To provide further evidence that HC can reduce the surface to cytoplasm ratio of TLR4 in immature colon, FHC cells were exposed to PBS (Figure 6a) or HC (Figure 6b) . After 5 d, the surface to cytoplasm ratio of TLR4 was noted to be significantly reduced in HC-treated cells (Figure 6c ) suggesting that this response may account for its effect in reducing LPSinduced TLR4 signaling.
DISCUSSION
In this study, we have systematically examined TLR4 expression in fetal and neonatal human and mouse colonic epithelium. Our observations by morphologic quantitation and by a functional TLR4 response to LPS stimulation suggests that the TLR response to LPS stimulation appears to be developmentally regulated. Further support of this conclusion comes from the effect of a trophic hormone, HC (known to be present in both amniotic fluid and breast milk) on the surface to cytoplasmic ratio of TLR4 and a functional response of TLR4 to LPS stimulation in human fetal colonic tissue and a colonic cell line. In these experiments, exposure to HC resulted in maturation of TLR4 expression and function to that seen in the mature colon.
Since greater than 90% of NEC cases occur in premature infants weighing less than 1,500 g and involves severe inflammation and necrosis, principally of the distal small intestine and colon, it is generally assumed that a major risk factor is the interaction of colonizing bacteria with the immature intestine (1,2). In studies from this laboratory, using intestinal models of fetal human intestine (16), we have reported that unlike mature enterocytes, the immature enterocyte responds excessively to an exogenous (LPS) and endogenous (IL-1β) stimulus (17, 18) . More recently, we have reported that an immature expression of innate immune response genes may contribute to this excessive inflammatory response (19) . As part of these studies, we have reported an increased expression of TLR4 in immature human fetal intestine. This study was designed to determine the developmental role of TLR4 expression and its response to LPS stimulation in human and mouse colonocytes. In a previous publication, we have reported for the first time that TLR4 was expressed on the basal lateral surface of a human primary fetal small intestinal cell line (H4 cells) and transcription was upregulated by inflammation (14). 
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Since that observation was published, other investigators have provided evidence implicating TLR4 in the pathogenesis of NEC. The Hackam group has reported that the expression of TLR4 is significantly greater in the premature mouse and human small intestine compared with their full-term counterpart and the expression of TLR4 is significantly elevated under conditions that are particularly relevant to the pathogenesis of NEC, namely the presence of hypoxia and exogenous bacteria expression of LPS (15, (20) (21) (22) . In premature infants, TLR4 signaling within the small intestinal epithelium has been shown to regulate apoptosis, proliferation, and migration of enterocytes, the differentiation of goblet cells, and to reduce microcirculatory perfusion conditions, which collectively contribute to the development of NEC (3, (12) (13) (14) (15) (16) (17) (19) (20) (21) (22) (23) . Furthermore, the Caplan Research Group has shown that a TLR4 knockout mouse model cannot develop experimental NEC (24) suggesting a prominent role for this receptor and its signaling molecules in the pathogenesis of this disease. Despite these observations, the expression of TLR4 in developing colon has not been extensively studied. Accordingly, in this study, we have shown that fetal and early neonatal expression of TLR4 is much higher than in mature intestine. Furthermore, the earlier fetal colonic specimens have a higher surface to cytoplasmic ratio. We believe that this developmental expression of TLR4 in colonic cells likely contributes to the increased IL-6 response to LPS stimulation between immature and mature colon. Since the intrauterine environment is free of bacteria, the increased surface expression of this receptor may serve another function, e.g., as a developmental regulator in a manner similar to that which exists in the Drosophila.Toll was first discovered in Drosophila as a gene that controlled the dorsal-ventral axis of the developing embryo. Subsequently, TLR4 in the more mature Drosophila was noted to have an innate immune function. However, the functional significance of TLR4 other than for innate immunity in human intestine remains largely unknown (25) . It is possible that TLR4 in human fetal intestine may have another function.
We know that the gastrointestinal tract in the extrauterine environment downregulates the transcription of TLR4 and the receptor is internalized to minimize unnecessary inflammation (12, 25) . To prepare for full-term delivery, the fetus in the later stages of gestation is exposed to trophic factors in amniotic fluid, which cause maturation of the intestine. Previous observations (6, 8, 9, 26) suggest that HC affects intestinal maturation at multiple levels. Thus, we hypothesized that HC may play a role in colonic TLR4 expression. To address this hypothesis, we treated human fetal colon tissues with HC at gestational age 16 wk leading to the reduction of the TLR4 surface to cytoplasm ratio. A similar result was observed in a fetal human colonic epithelial cell line (FHC). These observations suggest that HC affects the regulation of TLR4 expression causing the immature colon to express a mature colonocyte phenotype.
It has been suggested that TLR4 location and cellular trafficking affects its function (27) (28) (29) . TLR4 engages two distinct adaptor proteins: MyD88 which is recruited by TIRAP and elicits the production of proinflammatory cytokines and TRIF, which is recruited by the adaptor TRAM and activates the production of type 1 interferon as well as proinflammatory cytokines. Kagan et al. (13) have shown that TLR4 signals through TIRAP-MyD88 and TRAM-TRIF sequentially rather than simultaneously. Their data indicate that endocytosis of TLR4 terminates the initial phase of MyD88-dependent signaling and heralds the start of a second phase of TRIF-dependent signal transduction from TLR4 molecules located in endosome activated IRF3 for production of type 1 interferon (11-13). These reports suggest that the TLR4 activity is closely related to its location. Based on the difference of regional and spatial localization of TLR4 in immature and mature colon, we compared the proinflammatory response of TLR4 in human and mouse colon and found that with both LPS induced IL-6 induction was only observed in the immature colon which expressed high levels of TLR4 and more surface expression. In addition, IL-6 induction can be inhibited by pretreatment with HC which alters TLR4 expression from an immature to a mature pattern by reducing the surface to cytoplasm ratio. Our results suggest that the quantity, location of TLR4, and maturation effector HC are important for TLR4 signaling function in the immature colon.
Furthermore, in mouse colon, although the quantity of TLR4 continued to be high until the first day after birth, the surface to cytoplasm ratio of TLR4 was decreased. This result suggests that colonizing microbiota may in part regulate the distribution of TLR4 immediately after birth as has been previously suggested (3, 29) . Although it is inappropriate to obtain the colonic tissue from infants at day 1 after birth, our murine model observations might be extrapolated to suggest what happens in humans.
In these experiments, TLR4 expression and its proinflammatory response to LPS may be influenced by fetal age, exposure to trophic amniotic factors, and early neonatal colonization. However, NEC is complex and may be caused by multiple additional factors that affect intestinal injury and repair. For example, in mature cells, TLR4 and an intracellular receptor TLR9 interact to affect proliferation and repair of tissue damage (3). Why the relationship does not exist in premature infants with its effect favoring inflammation must be determined in future studies.
In summary, the quantity and location of TLR4 in colonic epithelium appears to be developmentally regulated by a combination of genetic preprogramming, trophic factors and luminal microbiota, which in turn affect TLR4 function in the developing colon. This study for the first time provides insight into TLR4 expression in developing colon and may contribute to a better understanding of TLR4-specific contributions to NEC development and possibly provide a new TLR4-signaling specific therapeutic approach to preventing NEC.
METHODS
Human Intestinal Tissue
All specimens were collected with informed consent approved by the Human Studies Committee at the Massachusetts General Hospital (protocol # 1999-P-003833). Human fetal colonic tissues were obtained from prostaglandin/saline-induced aborted fetuses at gestational ages of 10, 16, and 21 wk (n = 3-4 per age group). Surgically resected marginal colonic tissues (n = 3) were obtained from patients undergoing intestinal resection for clinical indications. Tissues were maintained in 1066 media (Life Technologies, Rockville, MD) containing 100 U/ml penicillin and 100 µg/ml streptomycin (17) . The fetal large intestine was identified as intestine between the appendix and anus. Tissues were washed with cold PBS at 4 °C, fixed in 4% paraformaldehyde at 4 °C overnight, then washed with PBS containing 30% sucrose, balanced in the same solution at 4 °C overnight, and embedded in optimal cutting temperature compound (Sakura Finetek USA, Torrance, CA). Frozen sections (5-µm thick) were kept at −20 °C for later use.
Human Colonic Organ Culture
Sixteen-week gestational aged human colonic tissues were collected (n = 3), cut into 3-mm pieces and cultured in BD-Falcon Tissue Culture Plates (Becton, Dickinson and Company, Franklin Lakes, NJ) with Opti-MEM media (Life Technologies, Grand Island, NY) supplemented with 10 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 2.5 mmol/l glutamine, 20 ng/ ml human epidermal growth factor, 10 µg/ml insulin, 4% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin, 2 mmol/l GlutaMAX-I at 37 °C with 95% O 2 , 5% CO2 (16) for 2 h, and then exposed to HC (1 µmol/l) or PBS for 20 h. Fixation and frozen sections were prepared as described above. Animals C57BL/6J mice were purchased from Jackson Laboratory (Bar Harbor, ME). All mice were bred and housed in a specific pathogenfree facility. Animals were given water and standard laboratory chow ad libitum. Timed pregnant mice were set up by pairing 10-12-wkold female mice with proven breeder males just prior to the end of the daily light cycle. The following morning, each female was examined for the presence of an ejaculatory plug in the vagina. When noted, the female was placed in a dated cage and considered pregnant, embryonic day (E) 0.5. Pups were delivered by caesarean delivery between day E16.5 and 18.5. Colonic tissues were collected for experiments. In addition viable mice were sacrificed on day 1, 3, 21, and 10 wk after birth and colon tissues collected. Animal procedures were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care and Use committee (A3596-01).
Prenatal HC Treatment
Pregnant C57BL/6J mice were injected subcutaneously with a single dose of HC (50 mg/kg body weight, n = 3) (6) or an equal volume of saline (n = 3) at day E14.5 and the fetal colonic tissues obtained at day E18.5 for experimental use.
Mouse Colonic Organ Culture
Mouse fetal colonic tissues were obtained at E 18.5 with or without HC treatment during pregnancy, and 10-wk-old adult mice colonic tissues were cut into 3-mm pieces and cultured under conditions described in the human colonic organ culture section. After 2 h at 37 °C, tissues were stimulated with ultra purified LPS 0111:B4 from Escherichia coli (List Biological Laboratories, Campbell, CA) or PBS for 45 min and 6 h. Supernatants were collected and stored at −20 °C for enzyme-linked immunosorbent assay (ELISA) analysis.
Cell Cultures
Normal nonimmortalized epithelial FHC were purchased from American Type Culture Collection (Manassas, VA) and maintained in the prescribed media. Briefly, 90% Dulbecco's modified Eagle medium: nutrient mixture F-12 media (American Type Culture Collection) and 10% fetal bovine serum (Mediatech, Manassa, VA), supplemented with 25 mmol/l HEPES (Life Technologies); 10 ng/ ml cholera toxin (Sigma Aldrich, St Louis, MO); 0.005 mg/ml insulin (Eli Lilly and Company, Indianapolis, IN); 0.005 mg/ml transferrin and 100 ng/ml (equal 0.2 µmol/l) HC (Sigma Aldrich); 100 U/ml penicillin and 100 µg/ml streptomycin (Life Technologies). Cells were maintained at 37 °C in 5% CO 2 , 95% O 2 in a humidified incubator. Human adult NCM460 colonocytes derived from normal colon were provided by INCELL (San Antonio, TX) and cultured in M3:Base A (M3A) media (INCELL), supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin. The cells were cultured at 37 °C in 5% CO 2 , and 95% O 2 in a humidified incubator.
LPS and HC Cellular Exposure
FHC and NCM 460 cells were cultured in 24-well BD-Falcon tissue culture plates (Becton, Dickinson and Company). FHC cells, at 70% confluence, were treated with or without HC (1 µmol/l) for 5 d. The cells were then treated with or without 15 µg/ml ultrapurified LPS 0111:B4 from E. coli for 45 min and 6 h. Supernatants were collected and stored at −20 °C for ELISA analysis. NCM 460 cells at 90% confluence were also treated with or without LPS (15 µg/ml) for 45 min and 6 h and supernatants were then collected and stored at −20 °C for ELISA analysis.
Immunofluorescent Staining
The human or mouse colonic frozen sections were washed with PBS and blocked with 3% bovine serum albumin in PBS for 1 h. They were then incubated with Phycoerythrin (PE)-conjugated anti-human or mouse TLR4 antibody (1:20) (both eBioscience, San Diego, CA) or with mouse IgG2a kappa isotype antibody (1:20) as a negative control for human samples (eBioscience,) and anti-mouse IgG1κ isotype antibody (1:20) (eBioscience) as a negative control for mouse samples, all in 1% bovine serum albumin containing 0.3% saponin at 37 °C for 1 h, then washed three times with PBS and counter stained with fluorescein isothiocyanate-labeled anti-phospholipid antibody (1:400) as a cell membrane marker, in 1% bovine serum albumin containing 0.3% saponin (Life Technologies) at room temperature for 1 h. After three times washing with PBS, they were overstained with 1, 5-bis {[α-(di-methylamino) ethyl] amino}-4, 8-dihydroxyanthracene-9, 10-dione (DRAQ5) (1:1,000) (Life Technologies) for 20 min at room temperature for nuclear visualization. Specimens were then washed three times with PBS, mounted with ProLong Antifade Reagent (Life Technologies) and analyzed with a fluorescent Leica confocal microscope. FHC cells cultured on glass coverslips in six-well tissue culture
